Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, is related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes. Here, SIRT4 is linked to metabolic dysfunction-associated steatotic liver disease.